中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2015年
5期
124-126
,共3页
生长抑素%腹腔镜治疗%粘连性肠梗阻%临床疗效
生長抑素%腹腔鏡治療%粘連性腸梗阻%臨床療效
생장억소%복강경치료%점련성장경조%림상료효
somatostatin%laparoscopy%adhesive intestinal obstruction%clinical curative effect
目的:探讨注射用生长抑素对腹腔镜手术治疗粘连性肠梗阻疗效的影响。方法选择浙江省苍南县第二人民医院2013年1月~2014年5月收治粘连性肠梗阻患者80例,随机分为对照组和观察组,每组各40例;对照组:采用腹腔镜手术治疗,同时从患者入院后予以基础治疗;观察组:在对照组治疗的基础上予以生长抑素注射液。观察比较2组患者的治疗效果、胃肠减压引流量、肛门恢复排气时间、中转外科手术率、住院时间、术后镇痛数、术后并发症、随访观察治疗后1年内的复发率,并应用EORTC生命质量功能评分对2组患者术后生活质量进行评价。结果治疗后,对照组总有效率为85.00%,观察组总有效率为92.50%,2组比较差异无统计学意义(χ2=2.635);观察组患者胃肠减压量、肠蠕动恢复时间、肛门恢复排气时间、住院时间和中转外科手术率均显著少于对照组(P均<0.01);通过对2组患者EORTC生命质量测量评分比较,观察组显著高于对照组,差异有统计学意义(P均<0.01)。2组手术成功率均为100%,观察组术后镇痛数、随访1年的复发率均显著低于对照组( P<0.01);观察组并发症与对照组比较差异无统计学意义(χ2=2.813)。结论腹腔镜手术治疗粘连性肠梗阻的同时,给予生长抑素可以提高临床疗效,缩短患者恢复时间,降低复发率,提高生存治疗。
目的:探討註射用生長抑素對腹腔鏡手術治療粘連性腸梗阻療效的影響。方法選擇浙江省蒼南縣第二人民醫院2013年1月~2014年5月收治粘連性腸梗阻患者80例,隨機分為對照組和觀察組,每組各40例;對照組:採用腹腔鏡手術治療,同時從患者入院後予以基礎治療;觀察組:在對照組治療的基礎上予以生長抑素註射液。觀察比較2組患者的治療效果、胃腸減壓引流量、肛門恢複排氣時間、中轉外科手術率、住院時間、術後鎮痛數、術後併髮癥、隨訪觀察治療後1年內的複髮率,併應用EORTC生命質量功能評分對2組患者術後生活質量進行評價。結果治療後,對照組總有效率為85.00%,觀察組總有效率為92.50%,2組比較差異無統計學意義(χ2=2.635);觀察組患者胃腸減壓量、腸蠕動恢複時間、肛門恢複排氣時間、住院時間和中轉外科手術率均顯著少于對照組(P均<0.01);通過對2組患者EORTC生命質量測量評分比較,觀察組顯著高于對照組,差異有統計學意義(P均<0.01)。2組手術成功率均為100%,觀察組術後鎮痛數、隨訪1年的複髮率均顯著低于對照組( P<0.01);觀察組併髮癥與對照組比較差異無統計學意義(χ2=2.813)。結論腹腔鏡手術治療粘連性腸梗阻的同時,給予生長抑素可以提高臨床療效,縮短患者恢複時間,降低複髮率,提高生存治療。
목적:탐토주사용생장억소대복강경수술치료점련성장경조료효적영향。방법선택절강성창남현제이인민의원2013년1월~2014년5월수치점련성장경조환자80례,수궤분위대조조화관찰조,매조각40례;대조조:채용복강경수술치료,동시종환자입원후여이기출치료;관찰조:재대조조치료적기출상여이생장억소주사액。관찰비교2조환자적치료효과、위장감압인류량、항문회복배기시간、중전외과수술솔、주원시간、술후진통수、술후병발증、수방관찰치료후1년내적복발솔,병응용EORTC생명질량공능평분대2조환자술후생활질량진행평개。결과치료후,대조조총유효솔위85.00%,관찰조총유효솔위92.50%,2조비교차이무통계학의의(χ2=2.635);관찰조환자위장감압량、장연동회복시간、항문회복배기시간、주원시간화중전외과수술솔균현저소우대조조(P균<0.01);통과대2조환자EORTC생명질량측량평분비교,관찰조현저고우대조조,차이유통계학의의(P균<0.01)。2조수술성공솔균위100%,관찰조술후진통수、수방1년적복발솔균현저저우대조조( P<0.01);관찰조병발증여대조조비교차이무통계학의의(χ2=2.813)。결론복강경수술치료점련성장경조적동시,급여생장억소가이제고림상료효,축단환자회복시간,강저복발솔,제고생존치료。
Objective To investigate somatostatin effect of on curative effect of laparoscopic operation in treatment of adhesive intestinal obstruction.Methods 80 patients with adhesive intestinal obstruction from January 2013 to May 2014, were randomly divided into control group and observation group, 40 cases in each group; the control group: treated with laparoscopic operation at the same time, from the patients admitted to the hospital after the foundation treatment; the observation group: somatostatin injection based on the treatment in control group.To observe the therapeutic effect of two groups, gastrointestinal decompression drainage, anal exhaust time, hospitalization time, the rate of conversion to surgical operation, postoperative analgesia, postoperative complications, follow-up treatment within 1 years after the recurrence rate, and application of functional EORTC life quality evaluation of the quality of life of two groups of patients with postoperative score.Results After treatment, the total effective rate of control group was 85%, the total efficiency of observation group was 92.50%, but the difference was not statistically significant (χ2 =2.635).After treatment, patients in observation group,the amount of gastrointestinal decompression, intestinal peristalsis recovery time, anal exhaust time, hospitalization time surgical operation and transfer rate were significantly lower than control group (P<0.01).By measuring the quality of life of EORTC scores between two groups, the observation group was significantly higher than the control group, there was significant difference ( P <0.01 ) .The success rate of the operation of the two groups was 100%, the observation group recurrence after 1 years of follow-up, the number of analgesic were significantly lower than the control group, there were significant differences.Complications in the observation group compared with the control group, the difference was not statistically significant (χ2 =2.813).Conclusion Laparoscopic operation in treatment of adhesive intestinal obstruction, given somatostatin can improve the clinical curative effect, shorten the recovery time of patients, reduce the recurrence rate, improve the survival of treatment.